渐进性多发性硬化症:疾病治疗,修复和恢复功能的前景
Daniel Ontaneda1, Alan J Thompson2, Robert J Fox1
1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Lancet (London, England)
|November 28, 2016
概括
目前的多发性硬化症疗法对疾病的进展形式无效. 需要新的治疗方法来解决神经退化和免疫机制导致进展性多发性硬化症的残疾.
科学领域:
- 神经学
- 免疫学
- 神经科学
背景情况:
- 多发性硬化症 (MS) 造成显著的神经障碍,特别是在渐进的形式.
- 虽然复发性缓解性多发性硬化症涉及炎症性病变,但进展性多发性硬化症的残疾源于扩散性免疫反应和神经退化.
- 已批准用于复发性缓解性多发性硬化症的现有抗炎药物在没有活性病变的渐进性多发性硬化症中具有有限的疗效.
研究的目的:
- 审查当前治疗多发性硬化症的情况.
- 确定治疗渐进性多发性硬化症的未满足需求.
- 讨论未来多发性硬化症治疗策略.
主要方法:
- 对进展性多发性硬化症现有治疗方法的文献综述.
- 对渐进性多发性硬化症的病理机制的分析.
- 综合现有研究和未来治疗多发性硬化症的方向.
主要成果:
- 目前用于复发性缓解性多发性硬化症的治疗方法在很大程度上对进展性多发性硬化症无效.
- 进展性多发性硬化症的特征是神经退化和扩散免疫机制, 不仅仅是焦点病变.
- 对于能够预防恶化,修复损伤和恢复进展性多发性硬化症的疗法,
结论:
- 对于渐进的多发性硬化症有效的疗法仍然是一个关键的未满足需求.
- 未来的研究应该集中在针对神经退行和扩散免疫过程上.
- 开发可以扭转损伤和恢复功能的治疗方法对于改善进展性多发性硬化症的结果至关重要.
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K


